OLMA logo

OLMA
Olema Pharmaceuticals Inc

1,809
Mkt Cap
$1.23B
Volume
8.3M
52W High
$36.26
52W Low
$2.86
PE Ratio
-7.55
OLMA Fundamentals
Price
$14.08
Prev Close
$14.96
Open
$14.96
50D MA
$23.15
Beta
0.97
Avg. Volume
1.42M
EPS (Annual)
-$1.87
P/B
2.39
Rev/Employee
$0.00
$1,673.91
Loading...
Loading...
News
all
press releases
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
Key PointsParadigm Biocapital Advisor increased its stake in Olema Pharmaceuticals by 750,000 shares in Q4 2025...
Nasdaq News: Markets·15h ago
News Placeholder
More News
News Placeholder
Jefferies Financial Group Begins Coverage on Olema Pharmaceuticals (NASDAQ:OLMA)
Jefferies Financial Group assumed coverage on Olema Pharmaceuticals in a report on Thursday. They issued a "buy" rating for the company...
MarketBeat·4d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
JPMorgan Chase & Co. lifted their target price on Olema Pharmaceuticals from $55.00 to $58.00 and gave the company an "overweight" rating in a research note on Wednesday...
MarketBeat·5d ago
News Placeholder
Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Olema Pharmaceuticals (OLMA) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·5d ago
News Placeholder
The Goldman Sachs Group Issues Pessimistic Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price
The Goldman Sachs Group cut their target price on shares of Olema Pharmaceuticals from $38.00 to $27.00 and set a "buy" rating for the company in a research note on Wednesday...
MarketBeat·5d ago
News Placeholder
HC Wainwright Issues Optimistic Outlook for OLMA Earnings
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) - Investment analysts at HC Wainwright raised their Q1 2026 earnings per share estimates for Olema Pharmaceuticals in a report issued on...
MarketBeat·5d ago
News Placeholder
Citigroup Forecasts Strong Price Appreciation for Olema Pharmaceuticals (NASDAQ:OLMA) Stock
Citigroup boosted their price objective on shares of Olema Pharmaceuticals from $60.00 to $62.00 and gave the company a "buy" rating in a research note on Tuesday...
MarketBeat·6d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 5.2% Following Analyst Downgrade
Olema Pharmaceuticals (NASDAQ:OLMA) Trading Down 5.2% Following Analyst Downgrade...
MarketBeat·6d ago
News Placeholder
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Cut to $38.00 by Analysts at Guggenheim
Guggenheim lowered their target price on Olema Pharmaceuticals from $40.00 to $38.00 and set a "buy" rating on the stock in a research note on Tuesday...
MarketBeat·6d ago
News Placeholder
Biotech Stock Up Nearly 300% Draws $68.7 Million Bet as Breast Cancer Drug Targets 2027 Launch
Key PointsCormorant Asset Management established a new stake in Olema Pharmaceuticals, purchasing 2,750,000 shares in the fourth quarter...
Nasdaq News: Markets·6d ago
<
1
2
...
>

Latest OLMA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.